144 related articles for article (PubMed ID: 38170019)
1. The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response.
Landolina N; Mariotti FR; Pelosi A; D'Oria V; Ingegnere T; Alicata C; Vacca P; Moretta L; Maggi E
Oncoimmunology; 2024; 13(1):2297504. PubMed ID: 38170019
[TBL] [Abstract][Full Text] [Related]
2. IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells.
Landolina N; Mariotti FR; Ingegnere T; Alicata C; Ricci B; Pelosi A; Veneziani I; Azzarone BG; Garlanda C; Mantovani A; Moretta L; Maggi E
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292515
[TBL] [Abstract][Full Text] [Related]
3. High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.
Campesato LF; Silva APM; Cordeiro L; Correa BR; Navarro FCP; Zanin RF; Marçola M; Inoue LT; Duarte ML; Molgora M; Pasqualini F; Massara M; Galante P; Barroso-Sousa R; Polentarutti N; Riva F; Costa ET; Mantovani A; Garlanda C; Camargo AA
Oncotarget; 2017 Jul; 8(30):49470-49483. PubMed ID: 28533483
[TBL] [Abstract][Full Text] [Related]
4. IL-1R8 expression in DLBCL regulates NK cell recruitment and influences patient prognosis.
Yu M; Zhang Q; Wan L; Wang S; Zou L; Chen Z; Li F
Funct Integr Genomics; 2023 Nov; 23(4):328. PubMed ID: 37907630
[TBL] [Abstract][Full Text] [Related]
5. IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC.
Mariotti FR; Supino D; Landolina N; Garlanda C; Mantovani A; Moretta L; Maggi E
Semin Immunol; 2023 Mar; 66():101712. PubMed ID: 36753974
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
7. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
[TBL] [Abstract][Full Text] [Related]
8. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.
Ciaglia E; Pisanti S; Picardi P; Laezza C; Sosa S; Tubaro A; Vitale M; Gazzerro P; Malfitano AM; Bifulco M
Pharmacol Res; 2014 Nov; 89():1-10. PubMed ID: 25063359
[TBL] [Abstract][Full Text] [Related]
9. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
Bonanni V; Antonangeli F; Santoni A; Bernardini G
J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
[TBL] [Abstract][Full Text] [Related]
10. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
[TBL] [Abstract][Full Text] [Related]
11. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
[TBL] [Abstract][Full Text] [Related]
12. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival.
Perez SA; Mahaira LG; Demirtzoglou FJ; Sotiropoulou PA; Ioannidis P; Iliopoulou EG; Gritzapis AD; Sotiriadou NN; Baxevanis CN; Papamichail M
Blood; 2005 Jul; 106(1):158-66. PubMed ID: 15755904
[TBL] [Abstract][Full Text] [Related]
13. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation.
Li L; Wei J; Li S; Jacko AM; Weathington NM; Mallampalli RK; Zhao J; Zhao Y
EBioMedicine; 2019 Jul; 45():553-562. PubMed ID: 31204278
[TBL] [Abstract][Full Text] [Related]
16. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
[TBL] [Abstract][Full Text] [Related]
17. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
[TBL] [Abstract][Full Text] [Related]
18. Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon Cancer.
Gao L; Yang L; Zhang S; Ge Z; Su M; Shi Y; Wang X; Huang C
J Interferon Cytokine Res; 2021 Dec; 41(12):450-460. PubMed ID: 34935484
[TBL] [Abstract][Full Text] [Related]
19. A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.
Xiong Q; Zhang H; Ji X; Zhang Y; Shi G; Dai L; Cheng F; Wang H; Luo J; Xu J; Ji Y; Su X; Yang W; Zhang L; Deng H
Oncoimmunology; 2022; 11(1):2127282. PubMed ID: 36185809
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1.
Xu Y; Sun J; Sheard MA; Tran HC; Wan Z; Liu WY; Asgharzadeh S; Sposto R; Wu HW; Seeger RC
Cancer Immunol Immunother; 2013 Oct; 62(10):1637-48. PubMed ID: 23982484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
